Ph.D. Michael Exton - Chief Executive Officer, Director at LEXICON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
LXRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ph.D. Michael Exton since 29 Jan 2025

Holdings reported by Ph.D. Michael Exton for LEXICON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 1,509,790 $1,011,559 $0.6700 13 Feb 2025 Direct Common Stock
Stock Option (Right to Buy) 2,264,690 13 Feb 2025 Direct Common Stock

Transactions reported by Ph.D. Michael Exton for LEXICON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.